Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesTransplantation, AutologousTissue DonorsWhole-Body IrradiationKidney TransplantationGraft SurvivalAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ConditioningHistocompatibility TestingTransplantation ChimeraHematopoietic Stem CellsBone Marrow PurgingImmunosuppressive AgentsTissue and Organ ProcurementGraft RejectionBone Marrow DiseasesHistocompatibilityTreatment OutcomeBusulfanLiving DonorsTime FactorsOrgan TransplantationRetrospective StudiesBone Marrow ExaminationBone RemodelingRecurrenceCytomegalovirus InfectionsHematopoiesisTransplantation, IsogeneicHematologic NeoplasmsCyclophosphamideLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLBone Marrow NeoplasmsRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionCombined Modality TherapySurvival AnalysisHeart TransplantationTransplantationAcute DiseaseLung TransplantationCyclosporineHepatic Veno-Occlusive DiseaseBone DensityGraft vs Host ReactionLymphocyte DepletionLeukemia, MyeloidRemission InductionWaiting ListsColony-Forming Units AssayHLA AntigensSurvival RateLymphoma, Non-HodgkinHematologic DiseasesT-LymphocytesFollow-Up StudiesOpportunistic InfectionsMyelodysplastic SyndromesImmunocompromised HostTransplantsNuclear FamilyLeukocyte TransfusionBone ResorptionChimeraLiver FailureTransplantation ImmunologySevere Combined ImmunodeficiencyCell DifferentiationStem Cell TransplantationFatal OutcomePostoperative ComplicationsLymphocyte TransfusionDonor SelectionActuarial AnalysisLeukocyte CountSpleenFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsMice, Inbred BALB CDisease-Free SurvivalCells, CulturedPrognosisBone NeoplasmsProspective StudiesMultiple MyelomaPancytopeniaPancreas TransplantationCytomegalovirusAntilymphocyte Serum